Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

David Robert Jaap has worked on the following 310 EPO patent applications which have been published in the last five years:

EP11804061

POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN

IPC classification:
A61K 31/497, A61K 31/715
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11815299

INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

IPC classification:
A61K 39/245, A61K 39/25, A61K 39/275, A61K 39/285, C12N 7/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP11865332

RECOMBINANT SUBUNIT DENGUE VIRUS VACCINE

IPC classification:
A61K 39/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11769326

PYRIDONE DERIVATIVES

IPC classification:
A61K 31/44, C07D 213/69, C07D 401/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP11836929

HIV INTEGRASE INHIBITORS

IPC classification:
A61K 31/235, A61K 31/66
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11760037

NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE

IPC classification:
A01N 43/50, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11875249

FUSED HETEROCYCLIC AZAINDANE CARBOXAMIDE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP11796211

TETRAHYDROQUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61K 31/4725, A61P 25/00, C07D 215/00, C07D 215/48, C07D 401/06, C07D 401/14, C07D 405/14, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12749051

NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS

IPC classification:
A01N 43/58
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP10832046

FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A61K 31/4965, A61K 31/519, A61K 45/06, A61P 3/04, C07D 471/04, C07D 487/04, C07D 498/04, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11816846

POSITIVE ALLOSTERIC MODULATORS OF MGLUR2

IPC classification:
A01N 43/50, A61K 31/415, C07D 235/26, C07D 401/04, C07D 401/06, C07D 401/10, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/10, C07D 405/06, C07D 405/10, C07D 409/10, C07D 413/10, C07D 417/14, C07D 453/02, C07D 471/04, C07D 513/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12767839

C5-C6 OXACYCLIC-FUSED THIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/54, C07D 285/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12771100

5-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/54, A61K 31/541, A61P 25/16, A61P 25/28, C07D 279/12, C07D 417/04, C07D 417/12, C07D 417/14
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11787178

NAPHTHALENE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61K 31/16, A61P 25/04, A61P 25/20, A61P 25/28
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11839952

ENOLASE PEPTIDE CONJUGATE VACCINES AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 38/00, A61K 39/00, A61K 39/085, C07K 7/00, C07K 14/31, C12N 9/88
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12725988

CB-183,315 COMPOSITIONS AND RELATED METHODS

IPC classification:
A61K 9/14, A61K 9/20
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
Sandra M. Pohlman, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11815098

FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS

IPC classification:
A61K 31/497, A61K 31/4985, A61P 31/04, A61P 31/10, C07D 471/04, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11833017

FUSED TETRACYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A01N 43/42, A01N 43/58, A01N 43/64, A01N 43/90, A61P 31/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11833019

POLYCYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/404, A61K 31/4178, A61K 31/423, A61K 31/517, A61K 31/519, A61K 31/555, A61K 31/675, A61K 31/7056, A61K 38/00, A61K 38/12, A61K 45/06, A61P 31/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12801916

IMMOBILIZED TRANSAMINASES AND PROCESS FOR MAKING AND USING IMMOBILIZED TRANSAMINASE

IPC classification:
C07K 14/00, C12Q 1/52
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12803996

NOVEL CRYSTALLINE FORMS OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR

IPC classification:
A61K 31/4439, A61K 31/4985, A61K 31/513
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13163216

Heterocyclic aspartyl protease inhibitors

IPC classification:
A61K 31/513, A61P 25/28, C07D 239/20, C07D 401/04, C07D 401/10, C07D 403/04, C07D 405/04, C07D 409/14, C07D 411/04, C07D 417/04, C07D 417/14, C07D 495/20
Applicant:
Merck & Co. Inc.
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP12814549

BTK INHIBITORS

IPC classification:
A61K 31/437, A61K 31/4985, A61K 31/519, A61K 31/52, A61K 31/53, A61P 3/10, A61P 7/02, A61P 9/00, A61P 19/02, A61P 25/00, C07D 497/02
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12825781

2-SPIRO-SUBSTITUTED IMINOTHIAZINES AND THEIR MONO-AND DIOXIDES AS BACE INHIBITORS, COMPOSITIONS AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12830590

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/343, A61P 31/14, C07D 307/82, C07D 405/10
Applicant:
MSD Italia S.r.l.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12829739

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/343, A61P 31/12, A61P 31/14, C07D 307/82, C07D 307/83, C07D 405/04, C07D 405/14
Applicant:
MSD Italia S.r.l.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12829730

HETEROCYCLIC-SUBSTITUED BENZOFURAN DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/343, A61P 31/14, C07D 405/14, C07D 413/14
Applicant:
MSD Italia S.r.l.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12832311

SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07F 7/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12831707

SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07F 7/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12766769

COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/7076, A61P 31/00, C07H 19/20
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Jones Day
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP12831151

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
A01N 43/54
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12834277

PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/4155, A61K 31/4439, A61K 31/541, A61P 11/00, A61P 29/00, A61P 35/00, C07D 401/04, C07D 401/14, C07D 405/04, C07D 405/14, C07D 409/04, C07D 409/14, C07D 413/14, C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12833964

SUBSTITUTED PYRIMIDINES

IPC classification:
A01N 43/54, A61K 31/4965, A61K 31/50
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12833410

CYCLOALKYLNITRILE PYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/415, A61P 35/00, A61P 37/00, C07D 231/10
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12834358

ACYCLIC CYANOETHYLPYRAZOLES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/415, C07D 231/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12834521

SUBSTITUTED PYRIMIDINES

IPC classification:
A01N 43/54, A61K 31/4965, A61K 31/50
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12834379

CYANOMETHYLPYRAZOLE CARBOXAMIDES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/415, C07D 231/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13180590

Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes

IPC classification:
A61K 9/00, A61K 9/20, A61K 31/4162, A61P 3/10, C07D 487/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13180593

Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes

IPC classification:
A61K 9/20, A61K 31/4162, A61P 3/10, C07D 487/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13180592

Combination drugs comprising aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes

IPC classification:
A61K 9/20, A61K 31/4162, A61P 3/10, C07D 487/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12838515

AZAINDOLES AS JANUS KINASE INHIBITORS

IPC classification:
A01N 43/62
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12838571

3-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12838160

PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12776679

PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
A01N 43/62, A61K 31/55, C07D 249/06, C07D 413/04, C07D 413/14
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12780370

2-PYRIDYLOXY-4-NITRILE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4545, A61P 25/00, A61P 25/20, C07D 401/14, C07D 409/14, C07D 413/14, C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12780359

SUBSTITUTED 3',5'-CYCLIC PHOSPHATES OF PURINE NUCLEOTIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/7076, A61P 31/12, C07H 19/213
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP10784493

Heterocylic compounds as antagonists of the orexin receptors

IPC classification:
A61K 31/4375, A61K 31/4725, A61K 31/55, C07D 217/26, C07D 401/06, C07D 471/04
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844551

PROCESS FOR MAKING BETA 3 AGONISTS AND INTERMEDIATES

IPC classification:
A61K 31/427
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12843729

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/33, A61K 31/381, A61K 31/404, A61K 31/42, A61K 31/4245, A61K 31/428, A61K 31/4365, A61K 31/437, A61K 31/4439, A61K 31/4725, A61K 31/4985, A61P 31/18, C07D 277/28, C07D 333/20, C07D 409/12, C07D 413/12, C07D 417/12, C07D 417/14, C07D 471/04, C07D 487/04
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12842776

PROCESS FOR MAKING BETA 3 ANGONISTS AND INTERMEDIATES

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12845873

AMINOPYRIMIDINONES AS INTERLEUKIN RECEPTOR-ASSOCIATED KINASE INHIBITORS

IPC classification:
A01N 43/54
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12846336

COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/4035
Applicant:
MSD Italia S.r.l.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12846357

NANO-SUSPENSION PROCESS

IPC classification:
A61K 9/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12758300

INDOLE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS

IPC classification:
A61K 31/55, A61P 19/02, C07D 403/12, C07D 491/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12757995

SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS

IPC classification:
A01N 43/64, A61K 31/41, C07D 209/52, C07D 401/08, C07D 403/06, C07D 403/08, C07D 405/04, C07D 405/08, C07D 409/08, C07D 413/04, C07D 417/04, C07D 417/08, C07D 471/04, C07D 493/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11807331

PROTECTIVE VACCINE BASED ON STAPHYLOCOCCUS AUREUS PROTEIN SA2412

IPC classification:
A61K 39/085
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11783995

SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS

IPC classification:
A61K 31/438, A61P 3/00, A61P 3/04, A61P 3/06, A61P 3/10, A61P 25/22, A61P 25/24, C07D 498/10, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11812998

INHIBITION OF CYP3A DRUG METABOLISM

IPC classification:
A01N 37/18, A61K 38/07, A61K 38/21
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12846579

QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP11775453

PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
A01N 43/46, A61K 31/415, C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11792924

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
A61K 31/454, A61K 31/4545, A61K 31/5377, A61K 45/06, C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP11792941

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
A61K 31/44, C07D 401/14, C07D 413/14, C07D 417/04, C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP13188869

Method of treatment using fatty acid synthesis inhibitors

IPC classification:
A01N 43/04, A61K 31/195, A61K 31/70, A61P 3/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12851733

METHOD FOR PREPARATION OF ALUMINUM HYDROXYPHOSPHATE ADJUVANT

IPC classification:
A61K 39/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12771566

2'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/7042, A61K 31/7068, A61K 31/7072, A61K 45/06, C07H 19/06, C07H 19/10, C07H 19/11, C07H 19/12, C07H 19/16, C07H 19/20, C07H 19/207, C07H 19/213, C07H 21/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12771707

2'-AZIDO SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07H 19/06, C07H 19/10, C07H 19/11, C07H 19/12, C07H 19/16, C07H 19/20, C07H 19/207, C07H 19/213, C07H 21/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12850024

TRIAZOLOPYRIDINONE PDE10 INHIBITORS

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12800460

METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN

IPC classification:
C07H 21/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12855868

PYRROLOPYRIMIDINES AS JANUS KINASE INHIBITORS

IPC classification:
A61K 31/519, C07D 487/02, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12767881

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

IPC classification:
A61K 31/506, A61P 5/50, C07D 211/22, C07D 401/12, C07D 405/04, C07D 413/04, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 495/04, C07D 498/04, C07D 513/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12710633

TRICYCLIC GYRASE INHIBITORS

IPC classification:
A61K 31/495, A61P 31/04, C07D 487/04, C07D 487/14
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Lawrence Livermore National Security, LLC
Agent:
Multiple attorneys, F. R. Kelly & Co.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12860596

SUBSTITUTED PIPERIDINES AS HDM2 INHIBITORS

IPC classification:
A61K 31/497
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12735138

4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES BTK-INHIBITORS

IPC classification:
A61K 31/4985, A61P 19/08, A61P 29/00, A61P 31/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 519/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12733505

4 - IMIDAZOPYRIDAZIN- 1 -YL-BENZAMIDES AND 4 - IMIDAZOTRIAZIN- 1 - YL - BENZAMIDES AS BTK- INHIBITORS

IPC classification:
A61K 31/4985, A61P 19/08, A61P 29/00, A61P 31/00, A61P 35/00, A61P 37/00, C07D 487/04, C07D 519/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP12786166

N-LINKED QUINOLINEAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61K 31/4709, A61P 25/28, C07D 401/06, C07D 401/14, C07D 403/12, C07D 405/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11816747

STAPHYLOCOCCUS AUREUS SURFACE PROTEIN SA1789 AND PROTECTIVE VACCINE BASED THEREON

IPC classification:
A61K 39/00, A61K 39/085, A61K 39/38, C07K 14/195
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12800485

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS, AND METHODS OF TREATMENT

IPC classification:
A01N 43/40, A61K 31/445, C07D 211/22, C07D 211/24, C07D 401/04, C07D 401/14, C07D 405/14, C07D 413/04, C07D 413/14, C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12779558

PROCESSES FOR PREPARING INHIBITORS OF THE HEPATITIS C VIRUS

IPC classification:
A01N 43/90, C07D 209/52
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12773555

TASTE-MASKED FORMULATIONS OF RALTEGRAVIR

IPC classification:
A01N 43/82, A61K 9/00, A61K 9/16, A61K 9/20, A61K 9/50, A61K 31/41, A61K 31/513, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP12801127

IMIDAZOPYRIDIN-2-ONE DERIVATIVES

IPC classification:
C07D 471/04, C07D 513/04, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP14185954

Piperidinone carboxamide azaindane CGRP receptor antagonists

IPC classification:
A61K 31/437, A61K 31/519, A61P 9/08, C07D 471/10
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP12799914

CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS

IPC classification:
A01N 43/42, A61K 31/473, A61K 31/501, A61K 31/506, A61K 31/5377, C07D 215/00, C07D 221/16, C07D 401/04, C07D 401/06, C07D 401/10, C07D 401/12, C07D 405/06, C07D 405/12, C07D 409/12, C07D 413/04, C07D 413/12, C07D 417/10, C07D 417/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13709101

COMBINED SYNTHESIS ROUTE FOR ETONOGESTREL AND DESOGESTREL

IPC classification:
C07J 5/00, C07J 33/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13761100

BIS-QUARTERNARY CINCHONA ALKALOID SALTS AS ASYMMETRIC PHASE TRANSFER CATALYSTS

IPC classification:
C07D 453/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13768805

IMIDAZOLYL METHYL PIPERIDINE T-TYPE CALCIUM CHANNEL ANTAGONISTS

IPC classification:
C07D 471/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP12779536

DRUG SUBSTANCES, PHARMECEUTICAL COMPOSITIONS AND METHODS FOR PREPARING THE SAME

IPC classification:
A01N 43/90, C07D 209/52
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP12838717

2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

IPC classification:
A61P 37/00, C07D 401/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12838133

1,3-SUBSTITUTED AZETIDINE PDE10 INHIBITORS

IPC classification:
A61K 31/506, A61P 25/18, A61P 25/22, C07D 401/14, C07D 403/14, C07D 405/14, C07D 413/14, C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11827912

TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION

IPC classification:
A61K 31/437, A61K 31/4985, A61K 31/5365, A61P 31/12, A61P 31/14, C07D 471/04, C07D 487/04, C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13788440

PYRIDINE CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4709
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13787989

PERMEABLE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 513/04
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13787557

PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/90, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13727740

3',5'-CYCLIC PHOSPHORAMIDATE PRODRUGS FOR HCV INFECTION

IPC classification:
A61P 1/16, C07H 19/11
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP11733256

OXADIAZOLE BETA CARBOLINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS

IPC classification:
A61K 31/437, A61P 3/10, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13806343

SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
A61K 31/505, A61P 35/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13807108

IMIDAZOLYL ANALOGS AS SYK INHIBITORS

IPC classification:
A61K 31/50, A61K 31/501
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13807050

SUBSTITUTED PYRIDINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS

IPC classification:
A61K 31/505, A61P 35/00
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13730912

METHOD OF TREATING LYMPHOMA USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517, A61P 35/00
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
Stephan Held, Meissner Bolte & Partnerschaft mbB
Status:
EXAMINATION REQUESTED
EP11784010

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
A61K 31/506, A61P 3/04, A61P 3/10, C07D 401/14, C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13807800

PYRAZOLYL DERIVATIVES AS SYK INHIBITORS

IPC classification:
A61K 31/50, A61K 31/501
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13817154

MACROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

IPC classification:
A01N 43/54, A01N 45/00, A61K 31/70
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP13735516

SULFONAMIDE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

IPC classification:
A61K 31/454, A61K 31/496, A61K 31/4985, A61P 31/18, C07D 401/14, C07D 403/14, C07D 417/14, C07D 471/04, C07D 471/10, C07D 487/04, C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13819609

HIV TREATMENT WITH AMIDO-SUBSTITUTED PYRIMIDINONE DERIVATIVES

IPC classification:
A61K 31/506, A61P 31/18, C07D 413/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13823437

SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS HIV INTEGRASE INHIBITORS

IPC classification:
A61K 31/4375, A61P 31/18, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11828123

TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION

IPC classification:
A61K 31/437, A61K 31/4985, A61K 31/5365, A61P 31/14, C07D 471/04, C07D 471/22, C07D 487/04, C07D 491/22, C07D 493/22, C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13825992

alpha7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I

IPC classification:
A61K 31/18, A61K 31/415, C07C 311/08, C07C 311/37, C07C 311/48, C07C 311/49, C07D 213/74, C07D 231/38, C07D 237/20, C07D 239/42, C07D 239/47, C07D 241/20, C07D 261/14, C07D 277/42
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13760199

METHODS OF ADMINISTERING A 5,5-FUSED HETEROARYLENE HEPATITIS C VIRUS INHIBITOR FOR TREATING OF PREVENTING HEPATITIS C VIRUS INFECTION

IPC classification:
A61K 31/4184, A61P 1/16, A61P 31/14
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Jones Day
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP14199792

Ceftolozane antibiotic compositions

IPC classification:
A61K 9/00, A61K 9/19, A61K 31/431, A61K 31/546, A61K 47/02, A61K 47/12, A61K 47/18, A61P 31/00, A61P 31/04
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13763164

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/5377, A61P 31/18, C07D 265/30, C07D 265/32, C07D 413/06, C07D 413/12, C07D 413/14
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13765905

TRICYCLIC GYRASE INHIBITORS FOR USE AS ANTIBACTERIAL AGENTS

IPC classification:
C07D 487/04, C07D 487/16, C07D 487/22, C07D 498/22, C07D 515/22
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Lawrence Livermore National Security, LLC
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
Hans-Lothar Arth, ABK Patent, Trademark and Design Attorneys
Status:
GRANT OF PATENT INTENDED
EP13841687

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

IPC classification:
A61K 9/66, A61K 31/00, A61K 31/4545
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13840379

CRYSTALLINE FORM OF A REVERSE TRANSCRIPTASE INHIBITOR

IPC classification:
A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13773568

ESTERS AND MALONATES OF SATE PRODRUGS

IPC classification:
A61K 31/7076, A61P 31/14, C07H 19/16
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP13776702

5-PHENOXY-3H-PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS HIV REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/513, A61P 31/18, C07D 239/52, C07D 239/54, C07D 239/56, C07D 401/14, C07D 403/06, C07D 403/14, C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
The patent has been granted
EP13845052

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/415, A61K 31/44, C07D 231/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP13845875

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/44, A61K 31/505
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION IN PROGRESS
EP11760027

NOVEL SPIRO IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE

IPC classification:
A61K 31/4184, A61P 3/04, A61P 3/10, C07D 401/04, C07D 401/14, C07D 403/12, C07D 403/14, C07D 413/04, C07D 413/14, C07D 491/08, C07D 498/08
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13849733

N-SUBSTITUTED INDAZOLE SULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
A61K 31/416
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP13854994

PROCESS FOR MAKING AGGLOMERATES USING ACOUSTIC MIXING TECHNOLOGY

IPC classification:
A61K 9/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP13854671

CYCLOBUTYL BENZIMIDAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13855525

CYCLOPROPYL IMIDAZOPYRIDINE PDE10 INHIBITORS

IPC classification:
A61K 31/4188
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13854794

2 -ALKYNYL SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR TREATING VIRAL DISEASES

IPC classification:
A61K 31/7068, C07H 19/02, C07H 19/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP13855567

SECONDARY ALCOHOL SUBSITUTED TRIAZOLES AS PDE10 INHIBITORS

IPC classification:
A61K 31/4184
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP13795957

D-ALANINE ESTER OF RP-NUCLEOSIDE ANALOG

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/16
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP11827256

HCV NS3 PROTEASE INHIBITORS

IPC classification:
A01N 43/36, A61K 31/40
Applicant:
MSD Italia S.r.l.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13856512

SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/444
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP15157348

PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR

IPC classification:
A61K 31/4439, A61P 31/18, C07D 401/06
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP13858495

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP13860461

DISULFIDE MASKED PRODRUG COMPOSITIONS AND METHODS

IPC classification:
C07D 339/08
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13859616

NUCLEOSIDE KINASE BYPASS COMPOSITIONS AND METHODS

IPC classification:
C07D 339/08
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13860923

BIOCATALYTIC TRANSAMINATION PROCESS

IPC classification:
C07D 211/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13861391

REGIOSELECTIVE N-2 ARYLATION OF INDAZOLES

IPC classification:
A61K 31/454
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13860921

PROCESS FOR MAKING REVERSE TRANSCRIPTASE INHIBITORS

IPC classification:
A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP13862850

BACE INHIBITORS OF IMINOTHIADIAZINE DIOXIDES

IPC classification:
A61K 31/549, A61P 25/28, C07D 285/18
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13864799

4-PYRIDINONETRIAZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13818899

SUBSTITUTED IMIDAZOPYRIDINES AS HDM2 INHIBITORS

IPC classification:
A61K 31/437, A61K 31/498, A61K 31/5377, A61K 31/538, A61K 31/5383, A61K 31/541, A61K 31/553, A61P 35/00, C07D 471/04, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP13865426

GASTRO-RETENTIVE FORMULATIONS

IPC classification:
A61K 9/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP13864070

C5-SPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61K 31/497, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13865620

C5, C6 OXACYCLIC-FUSED IMINOTHIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS

IPC classification:
A61K 31/54, C07D 279/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP13864272

C6-AZASPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A01N 43/836, A61K 31/54, A61K 31/549, C07D 285/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13795959

D-ALANINE ESTER OF SP-NUCLEOSIDE ANALOG

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/16
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13867977

PIPERAZINE-SUBSTITUTED [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61K 31/4985, A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP15167719

INTRAUTERINE DEPOSIT

IPC classification:
A61F 6/14, A61K 9/00
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP15166422

METHOD OF TREATMENT USING FATTY ACID SYNTHESIS INHIBITORS

IPC classification:
A01N 43/04, A61K 31/195, A61K 31/70, A61P 3/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP13866588

HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61K 31/4985, A61K 31/519, A61P 25/16, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14741091

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

IPC classification:
C07D 473/08
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP13872073

THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/5365, A61P 31/14, C07D 409/14, C07D 498/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP13871363

HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/5365, A61P 31/14, C07D 409/14, C07D 498/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14743190

BTK INHIBITORS

IPC classification:
C07D 213/75
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14743619

BTK INHIBITORS

IPC classification:
A61K 31/519, A61K 31/52, C07D 253/06, C07D 487/04, C07D 519/00
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14745870

2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS

IPC classification:
C07D 473/34
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14749379

2,6,7 SUBSTITUTED PURINES AS HDM2 INHIBITORS

IPC classification:
A01N 43/90, A61K 31/52, A61K 31/535, C07D 413/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP11835398

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/27, A61K 31/428, A61P 31/18, C07C 311/29, C07C 311/41, C07D 277/62, C07D 413/12, C07D 417/12
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14760677

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A61K 31/415, C07D 231/56
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14761162

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A61K 31/415, C07D 231/56
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14761134

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A61K 31/415, C07D 231/56
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP14760553

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A61K 31/415, C07D 231/56
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
The patent has been granted
EP15177391

THERAPEUTIC COMPOSITIONS

IPC classification:
A61K 9/16, A61K 9/48, A61K 31/545, A61P 31/04
Applicant:
Cubist Pharmaceuticals, Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14770245

S-IMINO-S-OXO IMINOTHIADIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/55, C07D 285/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14770391

S-IMINO-S-OXO IMINOTHIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/55
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14768510

SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS

IPC classification:
A61K 31/501, C07D 237/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14767603

C2-AZASPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS

IPC classification:
A61K 31/547, A61P 25/28, C07D 417/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11846964

NOVEL FORMULATIONS WHICH MITIGATE AGITATION-INDUCED AGGREGATION OF IMMUNOGENIC COMPOSITIONS

IPC classification:
A01N 25/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
APPLICATION WITHDRAWN
EP14726464

2',4'-FLUORO NUCLEOSIDES FOR THE TREATMENT OF HCV

IPC classification:
A61K 31/7072, A61K 31/7076, A61P 31/14, C07H 19/06, C07H 19/10, C07H 19/16, C07H 19/20
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14787452

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF - III

IPC classification:
A61K 31/4427, A61K 31/506, A61P 25/28, A61P 29/00, C07D 401/12, C07D 401/14, C07D 403/12
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14798188

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

IPC classification:
A61K 31/5025, A61K 31/5365, A61P 31/18, C07D 471/16, C07D 487/16, C07D 491/16
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14725702

SLC2A TRANSPORTER INHIBITORS

IPC classification:
A61K 31/437, A61K 31/4985, A61P 3/00, A61P 25/00, A61P 29/00, A61P 35/00, A61P 37/00, C07D 471/04, C07D 487/04, C07D 519/00
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Jeffrey Nicholas Daniels, Page White & Farrer
Status:
EXAMINATION IN PROGRESS
EP14807813

COMPOSITIONS AND METHODS FOR TREATING CANCER

IPC classification:
C12Q 1/68
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14811133

FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS

IPC classification:
C07D 265/34
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14814201

CYCLIC PHOSPHONATE SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/66, A61K 31/7105, A61K 31/712
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14816671

HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

IPC classification:
A61K 31/343
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14816866

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
A61K 31/343
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION WITHDRAWN
EP14817438

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP11781053

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
A61K 31/454, A61K 31/4545, A61K 31/506, A61K 31/5377, A61P 3/00, C07D 401/04, C07D 401/14, C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11775468

HETEROCYCLIC QUINOLIZINE DERIVED M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

IPC classification:
A61K 31/47, A61P 25/28, C07D 471/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14822616

FORMULATIONS FOR CATHEPSIN K INHIBITORS WITH VITAMIN D

IPC classification:
A61K 31/277, C07C 255/46
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14823386

SUBSTITUTED AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES (IRAK-4)

IPC classification:
A61K 31/497, A61K 31/519, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11835401

SULFONAMIDES AS HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/27, A61K 31/415, A61K 31/421, A61K 31/426, A61K 31/427, A61K 31/4439, A61K 31/505, A61K 31/506, A61P 31/18, C07C 311/29, C07C 311/41, C07C 317/40, C07C 323/49, C07D 231/12, C07D 261/08, C07D 277/62, C07D 417/12, C07D 417/14
Applicant:
Merck Canada Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11852164

FUSED HETEROCYCLIC INDANE CARBOXAMIDE AS CGRP RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/015, A61K 31/437, A61K 31/522, A61P 25/06, C07D 471/04, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11745203

SUBSTITUTED AMINOTETRAHYDROTHIOPYRANS AND DERIVATIVES THEREOF AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES

IPC classification:
A61K 31/4162, A61K 31/42, A61K 31/519, A61P 3/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14831878

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 498/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14745163

PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517, A61P 35/02
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14748126

METHOD OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) USING A BET-BROMODOMAIN INHIBITOR

IPC classification:
A61K 31/5517, A61P 35/00
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14833751

OXAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/422, A61K 31/4525, A61K 31/454, C07D 413/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14834750

THIAZOLE OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/422, A61K 31/4525, A61K 31/454, C07D 413/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP11775458

NOVEL SPIROPIPERIDINE PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
C07D 221/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11783980

NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS

IPC classification:
C07D 235/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10798901

5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 31/381, A61K 31/424, A61K 31/429, A61P 31/12, C07D 487/04, C07D 491/048, C07D 495/04, C07D 498/04, C07D 513/04
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
Multiple attorneys, Jones Day
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP15197990

IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/54, C07B 59/00, C07D 285/18, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 417/04, C07D 417/12, C07D 417/14, C07D 471/04, C07D 495/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION IN PROGRESS
EP14838369

7A-HETEROCYCLE SUBSTITUTED- 6, 6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES

IPC classification:
A61K 31/44, C07D 405/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14837408

3'-PYRIDYL SUBSTITUTED- 6,6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES

IPC classification:
A61K 31/44, C07D 405/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14837215

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A01N 43/52, A01N 43/56, A61K 31/415
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14837743

7A-AMIDE SUBSTITUTED-6,6-DIFLUORO BICYCLIC HIMBACINE DERIVATIVES

IPC classification:
A61K 31/44, C07D 405/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14840833

ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN

IPC classification:
A01N 43/40
Applicant:
Merck Sharp & Dohme Ltd.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14840648

2,2-DIFLUORODIOXOLO A2A RECEPTOR ANTAGONISTS

IPC classification:
A01N 43/58, A01N 43/60
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP11794797

N-SUBSTITUTED AZETIDINE DERIVATIVES

IPC classification:
A61K 31/397, A61K 31/422, A61K 31/427, A61K 31/433, A61K 31/4439, A61P 5/30, C07D 205/04, C07D 405/12, C07D 409/12, C07D 409/14, C07D 413/12, C07D 417/12, C07D 417/14
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11840630

N-Piperidinone-indane carboxamides as CGRP receptor antagonists

IPC classification:
A61K 31/40, A61K 31/445, A61K 31/506, C07D 471/04, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
PATENT GRANTED
EP10795690

Amino-heteroaryl derivatives as HCN blockers

IPC classification:
A61K 31/435, A61K 31/497, A61K 31/506, A61K 31/53, A61P 25/00, C07D 213/73, C07D 239/42, C07D 401/12, C07D 403/12
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14844214

TRICYCLIC GYRASE INHIBITORS

IPC classification:
A61K 31/519, A61P 31/04, C07D 487/04, C07D 487/16, C07D 487/22, C07D 515/22
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Lawrence Livermore National Security, LLC
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP14844006

C5-SPIRO IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
GRANT OF PATENT INTENDED
EP14845934

TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

IPC classification:
A61K 31/17, A61K 31/41, A61P 29/00
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
APPLICATION WITHDRAWN
EP14787071

HEPATITIS C VIRUS INHIBITORS

IPC classification:
A61K 31/4184, A61P 31/14, C07D 495/04
Applicant:
IDENIX Pharmaceuticals Inc
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14848447

SOLID FORMS OF CEFTOLOZANE

IPC classification:
A61K 31/431, A61K 31/546, A61K 47/18
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14849935

SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS

IPC classification:
A01N 43/90, A61K 31/44, C07D 455/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14847937

FACTOR XIA INHIBITORS

IPC classification:
C07K 14/745
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
GRANT OF PATENT INTENDED
EP10832048

PYRIMIDINE ETHER DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A01N 43/54, A61K 31/505
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP14850990

NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS

IPC classification:
A61K 31/435, A61K 31/4439
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14852717

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61K 31/42, A61K 31/425, C07D 263/02, C07D 277/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14852979

3,3'-DISUBSTITUTED INDOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN

IPC classification:
A61K 31/404, C07D 209/02, C07D 209/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14852689

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
A61K 31/438, A61K 31/444, A61P 3/10, C07D 221/16, C07D 401/12, C07D 401/14
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14851664

FACTOR XIa INHIBITORS

IPC classification:
A61K 31/397, A61K 31/7088, C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
GRANT OF PATENT INTENDED
EP14790899

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A61K 31/421, A61K 31/422, A61K 31/427, A61K 31/496, A61K 31/5377, A61K 31/541, A61K 31/547, A61P 19/10, C07D 263/34, C07D 413/10, C07D 413/12, C07D 417/10, C07D 417/14, C07D 495/08, C07D 513/08
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14853289

METHODS AND INTERMEDIATES FOR PREPARING MACROLACTAMS

IPC classification:
C07B 39/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
GRANT OF PATENT INTENDED
EP14856853

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 405/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14858815

PROCESS FOR PREPARING TETRACYCLIC HETEROCYCLE COMPOUNDS

IPC classification:
C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14803272

D-ALANINE PHOSPHORAMIDATE PRONUCLEOTIDES OF 2'-METHYL 2'-FLUORO GUANOSINE NUCLEOSIDE COMPOUNDS FOR THE TREATMENT OF HCV

IPC classification:
A61K 31/7076, A61K 31/708, A61P 31/12, C07H 19/207
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14858933

PSEUDOPOLYMORPHS OF AN HCV NS5A INHIBITOR AND USES THEREOF

IPC classification:
C07D 401/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11784011

SUBSTITUTED SEVEN-MEMBERED HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OF DIABETES

IPC classification:
C07D 471/00, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
PATENT GRANTED
EP11847155

TRICYCLIC HETEROCYCLES USEFUL AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS

IPC classification:
A61K 31/522, A61P 3/10, C07D 487/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11840448

SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/7056, C07D 513/04, C07H 9/06
Applicant:
Merck & Co. Inc.
Applicant:
Alectos Therapeutics Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck & Co. Inc.
Status:
PATENT GRANTED
EP14861810

PIPERIDINE OR PIPERAZINE LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

IPC classification:
A61K 31/4196
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14862098

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
C07D 221/16
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14862387

ARYL LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

IPC classification:
A61K 31/4196
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14861985

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A61K 31/415, C07D 231/56
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP11747910

BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS

IPC classification:
A61K 31/4184, A61P 3/10, C07D 235/26, C07D 403/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14863138

COMPOSITION OF A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR

IPC classification:
A01N 43/40
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP11818600

SPIROXAZOLIDINONE COMPOUNDS

IPC classification:
A61K 31/42, A61P 3/00, A61P 9/00, A61P 25/00, C07D 498/10, C07D 519/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14805555

METHOD OF TREATING LEUKEMIA USING PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 9/10, A61K 9/14, A61K 9/16, A61K 9/48, A61K 31/167, A61K 31/4045, A61K 31/436, A61K 31/519, A61K 31/551, A61K 31/573, A61K 45/06, A61K 47/02, A61K 47/32, A61K 47/38, A61P 35/02
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14809782

METHOD OF TREATING NON-SMALL-CELL LUNG CANCER USING PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 9/10, A61K 9/14, A61K 9/16, A61K 9/48, A61K 31/436, A61K 31/4545, A61K 31/551, A61K 45/06, A61K 47/02, A61K 47/32, A61K 47/38, A61P 35/00
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14812112

2'-DICHLORO AND 2'-FLUORO-2'-CHLORO NUCLEOSIDE ANALOGUES FOR HCV INFECTION

IPC classification:
A61K 31/513, A61K 31/52, A61K 31/522, A61K 31/7064, A61P 31/14, C07D 405/04, C07D 473/18, C07D 473/40, C07F 9/6561, C07F 9/6574, C07H 5/02, C07H 11/04, C07H 19/10, C07H 19/11
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14802069

PHARMACEUTICAL FORMULATION COMPRISING LOSARTAN POTASSIUM AND CHLORTHALIDONE

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/46, A61K 31/4178
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14866477

BICYCLOAMINE-SUBSTITUTED-N-BENZENESULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS

IPC classification:
C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14868525

ANTIDIABETIC BICYCLIC COMPOUNDS

IPC classification:
A61K 31/075
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14809832

DRUG DELIVERY SYSTEM.

IPC classification:
A61K 9/00, A61K 31/565, A61K 31/569, A61K 47/32
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870523

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/519, A61K 31/52, C07D 473/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14869616

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
A61K 31/519, A61K 31/52, C07D 473/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14809831

DRUG DELIVERY SYSTEM FOR DELIVERY OF ANTI-VIRALS

IPC classification:
A61K 9/00, A61K 31/5025, A61K 31/506, A61K 47/32
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14872226

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
C07D 213/72
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14870755

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

IPC classification:
A61K 31/55, C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14872398

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/426
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP14871205

ERK INHIBITORS

IPC classification:
A61K 31/437
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14824315

4'-OR NUCLEOSIDES FOR THE TREATMENT OF HCV

IPC classification:
C07H 19/06, C07H 19/16
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION IN PROGRESS
EP14872077

HIV PROTEASE INHIBITORS

IPC classification:
C07D 265/32, C07D 413/12, C07D 413/14
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14872521

HIV PROTEASE INHIBITORS

IPC classification:
A61K 31/5375
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
EXAMINATION REQUESTED
EP14871886

IMINOTHIADIAZEPANE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/547
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14870683

FUSED TETRACYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

IPC classification:
C07D 493/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14872688

THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
C07D 213/72
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14870699

BTK INHIBITORS

IPC classification:
A61K 31/437, A61P 3/10, A61P 19/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872269

BTK INHIBITORS

IPC classification:
A61K 31/437, A61P 3/10, A61P 19/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14872471

C-6 SPIROCARBOCYCLIC IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/15
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14870903

ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS

IPC classification:
A61K 31/192, A61K 31/381
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14872578

MEDIA MILLING PROCESS FOR THE MANUFACTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS IN PROPELLANTS

IPC classification:
A61J 3/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14871057

FUSED BICYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN

IPC classification:
C07D 498/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP14873215

PYRIMIDONE CARBOXAMIDE COMPOUNDS AS PDE2 INHIBITORS

IPC classification:
A61K 31/513, A61P 25/18, A61P 25/22, A61P 25/28, C07D 239/36, C07D 401/12, C07D 401/14, C07D 405/12, C07D 405/14
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP14875049

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 471/10, C07D 487/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP15735293

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

IPC classification:
C07D 405/06, C07D 487/10
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15740935

ISOQUINOLINE DERIVATIVES AS MGAT2 INHIBITORS

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP16169994

4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS

IPC classification:
A61K 31/17, A61P 35/00, C07C 237/40, C07D 207/08
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15745823

ANTIDIABETIC COMPOUNDS

IPC classification:
A61K 31/33, A61K 31/34, C07C 15/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746725

NOVEL DISINTEGRATION SYSTEMS FOR PHARMACEUTICAL DOSAGE FORMS

IPC classification:
A61K 9/20
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746174

PHARMACEUTICAL COMPOSITION OF SELECTIVE HCV NS3/4A INHIBITORS

IPC classification:
A61K 31/498, A61P 31/12
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15746768

TABLET FORMULATION FOR CGRP-ACTIVE COMPOUNDS

IPC classification:
A61K 9/26, A61K 31/437, C07D 221/02
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Hoffmann Eitle PartmbB
Status:
EXAMINATION REQUESTED
EP15748475

FACTOR XIA INHIBITORS

IPC classification:
A01N 37/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15748558

FACTOR XIA INHIBITORS

IPC classification:
A01N 37/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, MSD UK
Status:
EXAMINATION REQUESTED
EP15748498

CATHEPSIN CYSTEINE PROTEASE INHIBITORS

IPC classification:
A01N 43/56
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15746312

ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/18
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15748866

FACTOR XIA INHIBITORS

IPC classification:
A01N 37/12
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15754598

METHOD FOR TREATING CANCER

IPC classification:
A61P 35/02
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15713053

SOLID FORMS OF A FLAVIVIRIDAE VIRUS INHIBITOR COMPOUND AND SALTS THEREOF

IPC classification:
A61K 31/4178, A61P 31/12, C07D 409/04
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15710076

SOLID PRODRUG FORMS OF 2'-CHLORO-2'-METHYL URIDINE FOR HCV

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/4184, A61K 31/7072, A61P 31/14, C07H 19/10
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP11700142

1H-[1,2,3]TRIAZOLO[4,5-C]PYRIDINE-4- CARBONITRILE DERIVATIVES AS CATHEPSIN S INHIBITORS

IPC classification:
A61K 31/437, A61P 29/00, C07D 471/04
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Merck Sharp & Dohme Ltd.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10833777

SUBSTITUTED BIARYL DERIVATIVES AND METHODS OF USE THEREOF

IPC classification:
A01N 43/00
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck & Co. Inc.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15761538

2-PYRAZINE CARBOXAMIDES AS SPLEEN TYROSINE KINASE INHIBITORS

IPC classification:
A61K 31/505, A61K 31/506
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15710533

INDOLE DERIVATIVES FOR USE IN MEDICINE

IPC classification:
A61K 31/404, A61K 31/4045, A61K 31/405, A61K 31/407, A61K 31/4184, A61K 31/4188, A61K 31/423, A61K 31/424, A61K 31/4355, A61K 31/437, A61P 25/00, A61P 31/00, A61P 35/00, A61P 37/00, A61P 43/00
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15780045

SITAGLIPTIN TANNATE COMPLEX

IPC classification:
A61K 31/4985, A61P 3/08, C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15782608

PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST

IPC classification:
A61K 31/423, A61K 31/551, C07D 413/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15786309

METHOD OF TREATING RESISTANT NON-HODGKIN LYMPHOMA, MEDULLOBLASTOMA, AND/OR ALK+NON-SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15785547

METHOD OF TREATING ACUTE MYELOID LEUKEMIA AND/OR ACUTE LYMPHOBLASTIC LEUKEMIA USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15723671

METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 31/5517, A61K 45/06
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15795833

ANTIDIABETIC TRICYCLIC COMPOUNDS

IPC classification:
A61K 31/415, A61K 31/438, A61P 3/10, C07D 221/16, C07D 401/12, C07D 405/12
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15800163

METHODS FOR TREATING CANCER WITH A WEE1 INHIBITOR

IPC classification:
A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15803641

C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 417/14
Applicant:
Merck & Co. Inc.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Status:
EXAMINATION REQUESTED
EP15802906

IMIDAZO-PYRAZINE DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

IPC classification:
C07D 487/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15806506

ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF

IPC classification:
A61K 31/18, C07C 311/08, C07C 311/37
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15730293

METHOD OF TREATING NON-SMALL CELL LUNG CANCER AND/OR SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS

IPC classification:
A61K 9/10, A61K 9/14, A61K 9/16, A61K 9/48, A61K 31/436, A61K 31/4545, A61K 31/551, A61K 45/06, A61K 47/02, A61K 47/32, A61K 47/38, A61P 35/00
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP16198994

PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT

IPC classification:
A61K 9/20, A61K 9/48, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
APPLICATION PUBLISHED
EP15814626

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS

IPC classification:
A61K 31/506
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15832439

SYNTHESIS OF CEPHALOSPORIN COMPOUNDS

IPC classification:
C07D 501/04
Applicant:
Merck Sharp & Dohme Corporation
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15753924

PHARMACEUTICAL COMPOUND

IPC classification:
A61K 31/415, A61K 31/4164, A61K 31/4192, A61K 31/4196, A61K 31/42, A61K 31/433, A61K 31/44, A61P 15/00, A61P 25/00, A61P 31/00, A61P 35/00
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP15836358

TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/4375
Applicant:
Merck Canada Inc.
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
EXAMINATION REQUESTED
EP17151348

ENGINEERED ANTI-IL-23 ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/00, A61P 37/00, C07K 16/24, C12N 15/13
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
The application has been published
EP15831704

NOVEL CRYSTALLINE FORMS OF A BACE INHIBITOR, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 285/16
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15840606

S-IMINO-S-OXO IMINOTHIAZINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07C 309/14, C07C 335/32, C07D 295/088
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15837783

COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

IPC classification:
A01N 43/42
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15841974

DIAZINE-FUSED AMIDINE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 471/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15843683

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 498/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15844485

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
A61K 31/4355
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15845304

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
A61K 31/4704
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15843799

INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
A61K 31/4355
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15847644

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15847222

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15846420

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15846218

INHIBITORS OF IRAK4 ACTIVITY

IPC classification:
A61K 31/444, A61K 31/506, A61K 45/06
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15846682

C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
C07D 513/14
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15848373

SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 401/14, C07D 471/04, C07D 471/20
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15849713

SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 239/26
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15848319

SUBSTITUTED PYRIDINE INHIBITORS OF HIF PROLYL HYDROXYLASE

IPC classification:
C07D 401/14, C07D 471/04, C07D 471/20
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15791278

INHIBITORS OF TRYPTOPHAN-2,3-DIOXYGENASE OR INDOLEAMINE-2,3-DIOXYGENASE

IPC classification:
A61K 31/472, A61K 31/4725, A61K 31/502, A61P 15/18, A61P 25/28, A61P 31/04, A61P 35/00
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15861650

AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

IPC classification:
A61K 31/497, C07D 241/26, C07D 413/04
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made
EP15864069

C5-C6-OXACYCLIC FUSED IMINOPYRIMIDINONE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE

IPC classification:
A61K 31/519
Applicant:
Merck & Co. Inc.
Agent:
David Robert Jaap, Merck Sharp & Dohme Corporation
Status:
Request for examination was made

Please Sign in to use this feature